CAS 489415-96-5

SBC-115076

CAS: 489415-96-5

Formel: C₃₁H₃₃N₃O₅

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 527.6108

Ref: IN-DA00DB96

SBC-115076

CAS: 489415-96-5

SBC-115076

Formel: C₃₁H₃₃N₃O₅

Reinheit: ≥95%

Molekulargewicht: 527.61

Ref: 54-BUP07855

SBC-115076

CAS: 489415-96-5

SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.

Formel: C₃₁H₃₃N₃O₅

Reinheit: 97.07% - 99.89%

Farbe und Form: Solid

Molekulargewicht: 527.61

Ref: TM-T2626

SBC-115076

CAS: 489415-96-5

4-(4-(Benzyloxy)-3-methylbenzoyl)-3-hydroxy-1-(3-morpholinopropyl)-5-(pyridin-4-yl)-1,5-dihydro-2H-pyrrol-2-one

Formel: C₃₁H₃₃N₃O₅

Reinheit: 99%

Molekulargewicht: 527.61

Ref: IN-DG630730

SBC-115,076

Kontrolliertes Produkt

CAS: 489415-96-5

Formel: C₃₁H₃₃N₃O₅

Farbe und Form: Neat

Molekulargewicht: 527.61

Ref: TR-S155000

SBC-115076

CAS: 489415-96-5

SBC-115076 is a monoclonal antibody that binds to the tumor necrosis factor-α (TNF-α) receptor and blocks TNF-α signaling. This drug has been shown to be effective in treating cardiac disease, malignant brain tumors, and atherosclerotic cardiovascular disease. The SBC-115076 antibody is activated by TNF-α, which is released from cells of the immune system or cancer cells. The SBC-115076 antibody prevents TNF-α from binding to its receptor on the surface of other cells and thus prevents activation of those cells. This drug has also been shown to be effective in inhibiting growth of cultured cells, such as cancer cells.

Formel: C₃₁H₃₃N₃O₅

Reinheit: Min. 95%

Molekulargewicht: 527.61 g/mol

Ref: 3D-PUA41596